Weekly Tech+Bio Highlights #72-73: Mid-Month Rundown
Mid-February highlights across AI drug discovery, gene therapy lane, IPO and M&A watch, and a few broader ecosystem notes
Not too much (relatively) happened so far this month on the techbio front we track, especially after the front-loaded start to January 2026. This issue is a mid-month rundown of the news we noted so far. If something stood out to you that we did not include, do let us know!
